• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

Global Immunology Partnering 2010-2015: Deal trends, players and financials

  • ID: 2229059
  • June 2015
  • Region: Global
  • 1000 Pages
  • CurrentPartnering

The Global Immunology Partnering 2010-2015 report provides an understanding and access to the immunology partnering deals and agreements entered into by the worlds leading healthcare companies.

The report provides a detailed understanding and analysis of how and why companies enter immunology partnering deals. The majority of deals are development stage whereby the licensee obtains a right or an option right to license the licensors immunology technology. These deals tend to be multicomponent, starting with collaborative R&D, and commercialization of outcomes.

This report provides details of the latest immunology agreements announced in the healthcare sector.

Understanding the flexibility of a prospective partner’s negotiated deals terms provides critical insight into the negotiation process in terms of what you can expect to achieve during the negotiation of terms. Whilst many smaller companies will be seeking details of the payments clauses, the devil is in the detail in terms of how payments are triggered – contract documents provide this insight where press releases and databases do not.

This report contains a comprehensive listing of READ MORE >

Note: Product cover images may vary from those shown

Executive Summary

Chapter 1 - Introduction

Chapter 2 - Trends in immunology dealmaking

2.1. Introduction
2.2. Immunology partnering over the years
2.3. Immunology partnering by deal type
2.4. Immunology partnering by industry sector
2.5. Immunology partnering by stage of development
2.6. Partnering by immunology specific technology type

Chapter 3 - Average financial deal terms for immunology partnering

3.1. Introduction
3.2. Disclosed financials terms for immunology partnering
3.3 Immunology partnering headline values
3.4 Immunology deal upfront payments
3.5 Immunology deal milestone payments
3.6 Immunology royalty rates

Chapter 4 - Leading immunology deals

4.1. Introduction
4.1. Most active in immunology partnering
4.2. Top immunology deals by value
4.3. Big pharma immunology dealmaking activity
4.4. Big biotech immunology dealmaking activity

Chapter 5 - Immunology contracts directory

5.1. Introduction
5.2. Immunology partnering by company A-Z
5.3. Immunology partnering stage of development
5.4. Immunology partnering by deal type
5.6. Immunology partnering by technology type

Appendices

Introduction
Appendix 1 - Directory of immunology deals by company A-Z 2010-2015-
Appendix 2 - Directory of immunology deals by stage of development 2010-2015
Appendix 3 - Directory of immunology deals by deal type 2010-2015
Appendix 4 - Directory of immunology deals by therapy area 2010-2015
Appendix 5 - Immunology partnering resource center
About

Table of figures

Figure 1: Immunology partnering since 2010
Figure 2: Immunology partnering by deal type since 2010
Figure 3: Immunology partnering by industry sector since 2010
Figure 4: Immunology partnering by stage of development since 2010
Figure 5: Immunology partnering by disease type since 2010
Figure 6: Immunology partnering by specific technology type since 2010
Figure 7: Immunology deals with a headline value - by stage of development
Figure 8: Immunology deals with upfront payment values - by stage of development
Figure 9: Immunology deals with milestone payment - by stage of development
Figure 10: Immunology deals with royalty rates
Figure 11: Active immunology dealmaking activity- 2010 to 2015
Figure 12: Top immunology deals by value since 2010
Figure 13: Big pharma - top 50 - immunology deals 2010 to 2015
Figure 14: Big pharma immunology deal frequency - 2010 to 2015
Figure 15: Big biotech - top 50 - immunology deals 2010 to 2015
Figure 16: Big biotech immunology deal frequency - 2010 to 2015
Figure 17: Online partnering resources
Figure 18: Forthcoming partnering events

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

AB Sciex Eli Lilly and Company B. Braun Melsungen AG Astellas Pharma, Inc. Hologic Corporation Merck & Co., Inc.